Your browser doesn't support javascript.
loading
Hierarchical Cluster and Region of Interest Analyses Based on Mass Spectrometry Imaging of Human Brain Tumours.
Hiratsuka, Takuya; Arakawa, Yoshiki; Yajima, Yuka; Kakimoto, Yu; Shima, Keisuke; Yamazaki, Yuzo; Ikegami, Masahiro; Yamamoto, Takushi; Fujiwake, Hideshi; Fujimoto, Koichi; Yamada, Norishige; Tsuruyama, Tatsuaki.
Afiliação
  • Hiratsuka T; Department of Drug and Discovery Medicine, Pathology Division, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan.
  • Arakawa Y; Department of Neural Surgery, Kyoto University Hospital, Kyoto, 606-8507, Japan.
  • Yajima Y; Department of Microbiology, Muroran Institute of Technology, Muroran, Hokkaido, 050-8585, Japan.
  • Kakimoto Y; Department of Forensic Medicine, Graduate School of Medicine, Tokai University School of Medicine, Isehara-Shimokasuya 143, Kanagawa, 259-1193, Japan.
  • Shima K; Kyoto Applications Development Center, Analytical & Measuring Instruments Division, Shimadzu Corporation, 1 Nishino-kyo-Kuwabara-cho, Kyoto, 604-8511, Japan.
  • Yamazaki Y; Kyoto Applications Development Center, Analytical & Measuring Instruments Division, Shimadzu Corporation, 1 Nishino-kyo-Kuwabara-cho, Kyoto, 604-8511, Japan.
  • Ikegami M; Kyoto Applications Development Center, Analytical & Measuring Instruments Division, Shimadzu Corporation, 1 Nishino-kyo-Kuwabara-cho, Kyoto, 604-8511, Japan.
  • Yamamoto T; Kyoto Applications Development Center, Analytical & Measuring Instruments Division, Shimadzu Corporation, 1 Nishino-kyo-Kuwabara-cho, Kyoto, 604-8511, Japan.
  • Fujiwake H; Research Center, Shimadzu General Services, Inc., 1 Nishino-kyo-Kuwabara-cho, Kyoto, 604-8511, Japan.
  • Fujimoto K; Department of Neural Surgery, Kyoto University Hospital, Kyoto, 606-8507, Japan.
  • Yamada N; Clinical bioresource centre, Kyoto University Hospital, Kyoto, 606-8507, Japan.
  • Tsuruyama T; Department of Drug and Discovery Medicine, Pathology Division, Kyoto University Graduate School of Medicine, Kyoto, 606-8501, Japan. tsuruyam@kuhp.kyoto-u.ac.jp.
Sci Rep ; 10(1): 5757, 2020 04 01.
Article em En | MEDLINE | ID: mdl-32238824
ABSTRACT
Imaging mass spectrometry (IMS) has been rarely used to examine specimens of human brain tumours. In the current study, high quality brain tumour samples were selected by tissue observation. Further, IMS analysis was combined with a new hierarchical cluster analysis (IMS-HCA) and region of interest analysis (IMS-ROI). IMS-HCA was successful in creating groups consisting of similar signal distribution images of glial fibrillary acidic protein (GFAP) and related multiple proteins in primary brain tumours. This clustering data suggested the relation of GFAP and these identified proteins in the brain tumorigenesis. Also, high levels of histone proteins, haemoglobin subunit α, tubulins, and GFAP were identified in a metastatic brain tumour using IMS-ROI. Our results show that IMS-HCA and IMS-ROI are promising techniques for identifying biomarkers using brain tumour samples.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Química Encefálica / Neoplasias Encefálicas / Proteínas Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Química Encefálica / Neoplasias Encefálicas / Proteínas Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article